TBXT and myeloid leukemia: Selected pathways included: cytokine-cytokine receptor interaction, leukocyte transendothelial migration, Jak-STAT signaling pathways, MAPK signaling pathways, natural killer cell-mediated cytotoxicity, apoptosis, Toll-like receptor signaling pathways, T & B cell receptor signaling pathways, arachidonic acid metabolism, insulin signaling pathways, neuroactive ligand-receptor interactions, focal adhesion, ubiquitin-mediated protein lysis, and chronic myeloid leukemia.